Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma

Neuro Oncol. 2020 Sep 29;22(9):1233-1234. doi: 10.1093/neuonc/noaa170.
No abstract available

MeSH terms

  • Cancer Vaccines*
  • Glioblastoma* / drug therapy
  • Humans
  • Immunotherapy

Substances

  • Cancer Vaccines

Associated data

  • ClinicalTrials.gov/NCT04277221
  • ClinicalTrials.gov/NCT02017717
  • ClinicalTrials.gov/NCT03548571
  • ClinicalTrials.gov/NCT04396860
  • ClinicalTrials.gov/NCT02667587
  • ClinicalTrials.gov/NCT02617589